Sanofi SA (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 232   

Articles published

SNY 54.70 0.00 (0.00%)
price chart
Pfizer Inc. (NYSE:PFE) May See Lawsuit as Sanofi SA (NYSE:SNY ...
Sanofi Pasteur, the vaccines division of Sanofi SA (ADR) (NYSE:SNY) [Trend Analysis] reported that The New England Journal of Medicine published optimistic results from a large-scale, multi-center efficacy trial, which found that Fluzone High-Dose ...
Related articles »  
Investor's Alert �MGIC Investment Corp. (NYSE:MTG), Sanofi SA (ADR) (NYSE ...
Birmingham, West Midlands - (TechSonian) - 08/29/2014 - Elitestockpicks.comis a Stock newsletter website that provides free daily alerts on hot Moving stocks.
Related articles »  
Today's Watch List: Banco Santander Brasil SA (ADR) (NYSE:BSBR), AbbVie Inc ...
French drug maker Sanofi SA (ADR) (NYSE:SNY) said Thursday its earnings soared in the second quarter thanks to lower accounting charges than a year earlier, and the company lifted it full-year profit forecast.
Related articles »  
Stocks on Trader's Radar � Sanofi SA (ADR) (NYSE:SNY), Sequenom, Inc ...
Las Vegas, NV - August 16, 2014 - (TechSonian) �Sanofi SA (ADR)(NYSE:SNY) reported that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone� High-Dose (Influenza ...
Notable Movers- Sanofi SA (ADR) (NYSE:SNY), Total SA (ADR) (NYSE:TOT ...
Sanofi SA (ADR) (NYSE:SNY) announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone� High-Dose (Influenza Vaccine) was more efficacious in preventing ...
Sanofi SA Given Neutral Rating at Zacks (SNY)
Sanofi SA (ADR) logo Zacks reissued their neutral rating on shares of Sanofi SA (NYSE:SNY) in a research report released on Monday morning.
Sanofi SA Rating Reiterated by Zacks (SNY)  Watch List News (press release)
Bayer AG Given �Neutral� Rating at Zacks (BAYRY)  Mideast Time
Related articles »  
Investor Takeaway: Petroleo Brasileiro Petrobras SA (ADR) (PBR), NII Holdings ...
They worry that the company's worldwide deal with Sanofi SA (ADR) (NYSE:SNY) may not been good news for their pockets, and there has been little to stop MannKind's stock from falling.
Eye Catching Stocks : MannKind Corp. (NASDAQ:MNKD), Petroleo Brasileiro ...  Markets Insider
Related articles »  
J&J And Bristol-Myers Changing The Myeloma Drug Landscape
Two players, Celgene Corporation (CELG) and Takeda Pharmaceutical Co Ltd (ADR) (TKPYY), have thus far dominated the myeloma market with their breakthrough drugs for years.
IBM Watson Discovery Advisor Aiding Medical Research
Big Blue also announced that pharma titans Johnson & Johnson (NYSE:JNJ) and Sanofi SA (ADR) (NYSE:SNY) are also working with IBM's Watson to assist in research initiatives.
Related articles »  
GlaxoSmithKline plc (ADR) (NYSE:GSK) Interested In Acquiring InterMune Inc ...
Tomahawk, WI 08/14/2014 (Basicsmedia) - Europe's biggest drug makers led by the likes of Sanofi SA (ADR) (NYSE:SNY) and GlaxoSmithKline plc (ADR) (NYSE:GSK) are said to be in a race against time, to table bids as they push to acquire InterMune Inc.
InterMune Stock Surges As Management Announces It Could Be Up For Sale  Bidness Etc
Option Bulls Active as InterMune Inc (ITMN) Soars On Buyout Buzz  Schaeffers Research (blog)
Related articles »